https://www.selleckchem.com/pr....oducts/pf-04965842.h
Little is known about current patterns of antithrombotic therapy in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) in clinical practice in Germany. The RIVA-PCI is aprospective, non-interventional, multicenter study with follow-up until hospital discharge including consecutive patients with AF undergoing PCI. Between January 2018 and March 2020, 1636 patients (elective in 52.6%, non-ST elevation acute coronary syndrome [NSTE-ACS] in 39.3%, ST-elevation myocardial infarction in 8.2%) from 5
Like
Comment
Share
